Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 GVR’s internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Global Cannabis Pharmaceuticals Market Outlook
2.2 Global Cannabis Pharmaceuticals Market Segment Outlook
2.3 Global Cannabis Pharmaceuticals Market Competitive Insight
2.4 Global Cannabis Pharmaceuticals Snapshot
Chapter 3 Global Cannabis Pharmaceuticals Market Variables, Trends, & Scope
3.1 Market Segmentation
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Penetration & Growth Prospects Mapping
3.4 Global Cannabis Pharmaceuticals Regulatory Scenario
3.5 Cannabis Pharmaceuticals - PESTEL Analysis
3.5.1. Political
3.5.2. Environmental
3.5.3 Social
3.5.4 Technology
3.5.5. Legal
3.5.6 Economic
3.6 Cannabis Pharmaceuticals - Porter’s Analysis
3.6.1. Threat of New Entrants
3.6.2 Bargaining Power of Buyers
3.6.3 Competitive Rivalry
3.6.4 Bargaining Power of Suppliers
3.6.5 Threat of Substitutes
3.7 Opportunity Analysis (2016 - 2019 - 2027)
3.8 Product Pipeline Analysis, By Stage
3.9 Key Deals and Strategic Alliances
3.10 Synthetic Cannabis Pharmaceuticals Overview
Chapter 4 Global Cannabis Pharmaceuticals Market: Brand Type Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Market: Brand Type Market Share Analysis, 2020 and 2028
4.3 Sativex
4.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
4.4 Epidiolex
4.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 5 Global Cannabis Pharmaceuticals Market: Regional Estimates & Trend Analysis, By Brand Type, Deployment Model and End-user
5.1 Global Cannabis Pharmaceuticals Market: Regional Movement Analysis
5.2 North America
5.2.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.2.2 U.S.
5.2.2.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.2.3 Canada
5.2.3.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3 Europe
5.3.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.2 U.K.
5.3.2.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.3 Germany
5.3.3.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.4 Italy
5.3.4.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.5 France
5.3.5.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.6 Netherland
5.3.6.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.7 Poland
5.3.7.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.8 Croatia
5.3.8.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.9 Czech Republic
5.3.9.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.3.10 Switzerland
5.3.10.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.4 Asia Pacific
5.4.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.4.2 Japan
5.4.2.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.4.3 South Korea
5.4.3.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.4.4 Australia
5.4.4.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.4.5 New Zealand
5.4.5.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5 Latin America
5.5.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.2 Brazil
5.5.2.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.3 Mexico
5.5.3.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.4 Argentina
5.5.4.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.5 Columbia
5.5.5.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.6 Uruguay
5.5.6.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.7 Chile
5.5.7.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.5.8 Peru
5.5.8.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.6 MEA
5.6.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
5.6.2 Israel
5.6.2.1 Market estimates and forecasts, by brand type, 2016 - 2028 (USD Million)
Chapter 6 Global Cannabis Pharmaceuticals Market: Competitive Analysis
6.1 Company Market Position Analysis
6.2 List of Key Emerging Players and Market Differentiators
6.3 Company Categorization
6.4 Brand Share Analysis, 2018-2020
Chapter 7 Competitive Landscape
7.1 GW Pharmaceuticals
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 AbbVie Inc.
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 Valeant Pharmaceuticals
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Insys Therapeutics, Inc.
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives



List of Figures

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Cannabis pharmaceuticals market snapshot, 2020 (USD Million)
FIG. 9 Cannabis pharmaceuticals market segmentation
FIG. 10 Cannabis pharmaceuticals market dynamics
FIG. 11 Cannabis pharmaceuticals market driver impact
FIG. 12 Cannabis pharmaceuticals market restraints impact
FIG. 13 Penetration & growth prospects mapping for cannabis pharmaceuticals market
FIG. 14 Cannabis Pharmaceuticals -PESTL Analysis
FIG. 15 Cannabis Pharmaceuticals -PORTER’s Analysis
FIG. 16 Opportunity analysis (USD Million)
FIG. 17 Cannabis Pharmaceuticals market, brand outlook: Key takeaways
FIG. 18 North America cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 19 U.S. cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 20 Canada cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 21 Europe cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 22 U.K. cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 23 Germany cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 24 France cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
Fig. 25 Italy cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 26 Netherlands cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 27 Poland cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 28 Croatia cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 29 Switzerland cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 30 Czech Republic cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 31 Asia Pacific cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 32 Japan cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 33 South Korea cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 34 Australia cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 35 New Zealand cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 36 Brazil cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 37 Mexico cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 38 Argentina cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 39 Colombia cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 40 Uruguay cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 41 Chile cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 42 Israel cannabis pharmaceuticals market estimates and forecasts, 2016 - 2028 (USD Million)

List of Tables


List of Tables

TABLE 1 List of Abbreviation
TABLE 2 North America cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 3 U.S. cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 4 Canada cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 5 Europe cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 6 U.K. cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 7 Germany cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 8 Italy cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 9 France cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 10 Netherland cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 11 Poland cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 12 Croatia cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 13 Czech Republic cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 14 Switzerland cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 15 Asia Pacific cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 16 Japan cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 17 South Korea cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 18 Australia cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 19 New Zealand cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 20 Latin America cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 21 Brazil cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 22 Mexico cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 23 Argentina cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 24 Columbia cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 25 Uruguay cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 26 Peru cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 27 Chile cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 28 MEA cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)
TABLE 29 Israel cannabis pharmaceuticals market, by brand type, 2016 - 2028 (USD Million)